Brubaker D B
Inland Northwest Blood Center, Washington State University, Spokane 99210.
Proc Soc Exp Biol Med. 1993 Feb;202(2):122-47. doi: 10.3181/00379727-202-43519b.
Posttransfusion graft-versus-host disease is a lethal adverse effect of blood transfusions affecting the skin, liver, gastrointestinal tract, and, in addition, the lymphohematopoietic systems. It is a disease that has been described for nearly three decades with well over 400 cases known worldwide; however, the immunopathogenesis has not been fully described. By using murine models, combined with human case reports, the immune mechanism and risk factors are outlined. The models and case reports prove a histocompatibility disparity between donor and recipient. The dose of lymphocytes in the products, types of T lymphocyte subsets in the products, and degree of immune suppression in the host are all factors necessary in the immunopathogenesis of posttransfusion graft-versus-host disease. The mechanism is that of acute, lethal, suppressive immune dysregulation in the host (recipient).
输血后移植物抗宿主病是输血的一种致命不良反应,可累及皮肤、肝脏、胃肠道,此外还可累及淋巴造血系统。这种疾病已被描述了近三十年,全球已知病例超过400例;然而,其免疫发病机制尚未完全阐明。通过使用小鼠模型并结合人类病例报告,概述了免疫机制和危险因素。这些模型和病例报告证实了供体和受体之间的组织相容性差异。产品中淋巴细胞的剂量、产品中T淋巴细胞亚群的类型以及宿主的免疫抑制程度都是输血后移植物抗宿主病免疫发病机制中的必要因素。其机制是宿主(受体)发生急性、致命性、抑制性免疫失调。